Bausch + Lomb’s stock soars 18% on report company is considering selling itself
Eyecare company is working with Goldman Sachs on a deal that would extricate it from its indebted parent, the Financial Times reported
Published:
The stock of eyecare company Bausch + Lomb Corp. was up 18% early Monday, after the Financial Times reported that the company is considering selling itself as a way to extricate itself from its indebted parent.
The company BLCO , which was carved out of parent Bausch Health Cos. Inc. BHC in 2022, is working with Goldman Sachs to explore a deal and expects to draw interest from private equity firms, the FT reported.